Furthermore, hyperglycemia upregulates glucose transporters (GLUT1 and GLUT3), thus further amplifying glucose uptake in certain cancers, a potential molecular mechanism contributing to the adjunct effect of glucose in tumor therapy [26]. Here, SLC2A1 is linked to Hyperglycemia.